


A $53 billion global leader in the chemicals industry lacked visibility into sales data needed to track and measure innovative products. This hindered effective benchmarking, prevented recognition of commercial potential of innovation, and obstructed the assessment of their competitive position.
A leading chemical company lacked a structured way to track and benchmark the performance of its new product innovations.
Without consistent visibility into how new products were performing in the market, teams struggled to assess impact, compare against competitors, or identify opportunities for improvement. As a result, a significant portion of new launches went untracked or under-analyzed, limiting the organization’s ability to maximize return on innovation.
Aligned Automation developed a Commercialization Index dashboard to centralize data, standardize benchmarking, and provide actionable insights into product performance.
The solution unified fragmented data sources into a single platform, enabling real-time visibility into key performance metrics and competitive positioning. Advanced analytics and visualization tools allowed teams to track, compare, and analyze new product performance at a granular level.
Key capabilities included:
Innovation management shifted from fragmented and reactive to structured and insight-driven.
The organization gained clear visibility into new product performance, improved benchmarking capabilities, and the ability to make faster, more informed decisions to maximize the commercial impact of its innovation portfolio.

